Therapeutic efficacy of halocidin-derived peptide HG1 in a mouse model of Candida albicans oral infection

Therapeutic Efficacy of Halocidin-Derived Peptide HG1 in a Mouse Model of Surgical Wound Infection with Methicillin-ResistantStaphylococcus aureus

(2011) Young Shin Lee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Growth of Candida albicans hyphae

(2011) Peter E. Sudbery   NATURE REVIEWS MICROBIOLOGY

Antimicrobial Activity of a Halocidin-Derived Peptide Resistant to Attacks by Proteases

(2010) Y. P. Shin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efflux-Mediated Antifungal Drug Resistance

(2009) R. D. Cannon et al.   CLINICAL MICROBIOLOGY REVIEWS

A Novel Immune Evasion Strategy of Candida albicans: Proteolytic Cleavage of a Salivary Antimicrobial Peptide

(2009) Timothy F. Meiller et al.   PLoS One

Amphotericin B: side effects and toxicity

(2009) Rafael Laniado-Laborín et al.   REVISTA IBEROAMERICANA DE MICOLOGIA

Therapeutic application of peptides and proteins: parenteral forever?

(2009) Zuzana Antosova et al.   TRENDS IN BIOTECHNOLOGY

Distribution and hydrolytic enzyme characteristics ofCandida albicansstrains isolated from diabetic patients and their non-diabetic consorts

(2009) M. F. G. Boriollo et al.   Oral microbiology and immunology

Oral mucosal fungal infections

(2008) Lakshman P. Samaranayake et al.   PERIODONTOLOGY 2000